Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
During Taste of Techstars, David Cohen offers three tips for hopeful applicants
Founder and co-CEO of Techstars David Cohen addressed Kansas City via a simulcast on Thursday morning, sharing three tips for startups. This preceded the day long workshop Taste of Techstars, which is hosted in multiple Techstars cities. Including simulcast talks, mentor sessions and pitch practice — Kansas City Techstars managing director Lesa Mitchell said she…
Google Fiber clarifies KC plans after reports of mass cancellations
After media reports indicated it canceled “hundreds” of area residents’ installations without a specific reason, Google Fiber is now clarifying its Kansas City plans. The tech giant — which began building an expansive gigabit network in Kansas City, Kan. in 2011 — said that while it remains committed to the area, it is tapering its expansion…
Leaders in KC coworking evaluate cultural, economic impact
Though I’m a “young, hip” millennial that offices in a coworking space, there’s no slant in saying that coworking is more than a fad in Kansas City. It’s a serious — and growing — business segment in the area. In the next 18 to 24 months, the metro will be welcoming more than 300,000 square…
Listen: Experts analyze KC’s evolving coworking and real estate market
What happens when the real estate market responds to a city’s surging entrepreneurial community? That was the subject of Startland News and Think Big’s March Innovation Exchange, which focused on Kansas City’s coworking boom and its intersection with area entrepreneurship. More than 300,000 square feet of coworking space will become available in the area over…